| First Author | Chiarella SE | Year | 2014 |
| Journal | J Clin Invest | Volume | 124 |
| Issue | 7 | Pages | 2935-46 |
| PubMed ID | 24865431 | Mgi Jnum | J:213275 |
| Mgi Id | MGI:5584039 | Doi | 10.1172/JCI75157 |
| Citation | Chiarella SE, et al. (2014) beta(2)-Adrenergic agonists augment air pollution-induced IL-6 release and thrombosis. J Clin Invest 124(7):2935-46 |
| abstractText | Acute exposure to particulate matter (PM) air pollution causes thrombotic cardiovascular events, leading to increased mortality rates; however, the link between PM and cardiovascular dysfunction is not completely understood. We have previously shown that the release of IL-6 from alveolar macrophages is required for a prothrombotic state and acceleration of thrombosis following exposure to PM. Here, we determined that PM exposure results in the systemic release of catecholamines, which engage the beta2-adrenergic receptor (beta2AR) on murine alveolar macrophages and augment the release of IL-6. In mice, beta2AR signaling promoted the development of a prothrombotic state that was sufficient to accelerate arterial thrombosis. In primary human alveolar macrophages, administration of a beta2AR agonist augmented IL-6 release, while the addition of a beta blocker inhibited PM-induced IL-6 release. Genetic loss or pharmacologic inhibition of the beta2AR on murine alveolar macrophages attenuated PM-induced IL-6 release and prothrombotic state. Furthermore, exogenous beta2AR agonist therapy further augmented these responses in alveolar macrophages through generation of mitochondrial ROS and subsequent increase of adenylyl cyclase activity. Together, these results link the activation of the sympathetic nervous system by beta2AR signaling with metabolism, lung inflammation, and an enhanced susceptibility to thrombotic cardiovascular events. |
